Evidence map›Paper›PMID 36897259›Full record

ArticleBlood advances2023

Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.

Ekin Guney, Calixto-Hope G Lucas, Kunwar Singh, Melike Pekmezci, Sebastian Fernandez-Pol, Kanish Mirchia, Angus Toland, Hannes Vogel, Serguei Bannykh, Kristian T Schafernak and 15 more

Abstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Digital and Manual Assessment of Intrafollicular Ki-67,Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ekin GuneyDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-7050-0831
Calixto-Hope G LucasDepartment of Pathology, University of California, San Francisco, San Francisco, CA.
Kunwar SinghDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-9024-5751
Melike PekmezciDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-2548-8359
Sebastian Fernandez-PolDepartment of Pathology, Stanford University Medical Center, Palo Alto, CA.ORCID 0000-0002-0428-0199
Kanish MirchiaDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-7371-7059
Angus TolandDepartment of Pathology, Stanford University Medical Center, Palo Alto, CA.
Hannes VogelDepartment of Pathology, Stanford University Medical Center, Palo Alto, CA.
Serguei BannykhDepartment of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Kristian T SchafernakDepartment of Pathology, Phoenix Children's Hospital, Phoenix, AZ.
Sanda AlexandrescuDepartment of Pathology, Harvard Medical School, Boston Children's Hospital, Boston, MA.ORCID 0000-0001-9246-4184
Bret C MobleyDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Suzanne PowellDepartment of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, TX.
Christian J DavidsonDepartment of Pathology, University of Utah Health, Salt Lake City, UT.
Janna NeltnerDepartment of Pathology & Laboratory Medicine, University of Kentucky Chandler Medical Center, Lexington, KY.
Daniel R BouéDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital and The Ohio State University, Columbus, OH.
Eyas HattabDepartment of Pathology and Laboratory Medicine, University of Louisville School of Medicine, Louisville, KY.
Sean P FerrisDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0001-5407-7212
Robert S OhgamiDepartment of Pathology, University of California, San Francisco, San Francisco, CA.
James L RubensteinDepartment of Medicine, University of California, San Francisco, San Francisco, CA.
Andrew W BollenDepartment of Pathology, University of California, San Francisco, San Francisco, CA.
Tarik TihanDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-4551-2555
Arie PerryDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-8300-7261
David A SolomonDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-4571-7999
Kwun Wah WenDepartment of Pathology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-8251-902X

Funding

Training Program in Translational Brain Tumor ResearchT32CA151022 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2010 to 2026
$6.6M
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS LymphomaR01CA239462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAUMEIL, MYRIAM MARIANNE, RUBENSTEIN, JAMES LOUIS · 2019 to 2023
$3.1M
Cohesin gene mutations in tumorigenesisDP5OD021403 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SOLOMON, DAVID A. · 2015 to 2019
$2.0M
NCI NIH HHS R01 CA239462NCI NIH HHS T32 CA151022NIH HHS DP5 OD021403
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epstein-Barr Virus InfectionsLymphoproliferative DisordersHumans

Identifiers

PMID36897259
PMCPMC10336256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.